Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 375 to 424 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
188\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-aminoadipate aminotransferase; l-kynurenine/alpha-aminoadipate aminotransferase; kynurenine aminotransferase ii. [source:refseq;acc:nm\_016228]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9986.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10741.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07558\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4571.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5864.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.28281\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
189\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
natural resistance-associated macrophage protein 1 (nramp 1). [source:swissprot;acc:p49279]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6933.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7456.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0754\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4571.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5864.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.28281\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
190\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kda subunit precursor (ec 2.4.1.119) (oligosaccharyl transferase 48 kda subunit) (ddost 48 kda subunit). [source:swissprot;acc:p39656]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-2 (e2f dimerization partner 2). [source:swissprot;acc:q14188]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6480.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6966.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07485\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
191\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to atp/gtp-binding protein. [source:sptrembl;acc:q8nem8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9385.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10086.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07469\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4638.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5923.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27712\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
192\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17757.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26767\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trna (5-methylaminomethyl-2-thiouridylate)-methyltransferase (ec 2.1.1.61). [source:swissprot;acc:o75648]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9385.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10086.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07469\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
193\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26766\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 7 (stard7) (start domain- containing protein 7) (gtt1 protein). [source:swissprot;acc:q9nqz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6534.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7021.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07451\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
194\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26743\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transmembrane protein tmp21 precursor (21 kda transmembrane trafficking protein) (p24delta) (s31iii125) (s31i125) (tmp-21-i). [source:swissprot;acc:p49755]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11403\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12252.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07446\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
195\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26743\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol glycan, class b. [source:refseq;acc:nm\_004855]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11403\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12252.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07446\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
196\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
natural resistance-associated macrophage protein 2 (nramp 2) (divalent metal transporter 1) (dmt1). [source:swissprot;acc:p49281]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6985.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7503.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07415\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26742\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
197\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
diacylglycerol kinase, eta isoform 1. [source:refseq;acc:nm\_152910]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6519.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6997.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07336\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26742\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
198\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17710.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13977.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26708\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
diacylglycerol kinase, delta (ec 2.7.1.107) (diglyceride kinase) (dgk-delta) (dag kinase delta) (130 kda diacylglycerol kinase) (fragment). [source:swissprot;acc:q16760]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6519.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6997.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07336\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
199\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
prohibitin. [source:swissprot;acc:p35232]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11422.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07334\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, catalytic subunit, alpha isoform (ec 3.1.3.16) (pp2a-alpha) (replication protein c) (rp-c). [source:swissprot;acc:p05323]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4916.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3888.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26455\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
200\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4808.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6074.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26315\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6926.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7434.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07324\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
201\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10392.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9683.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07323\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4810.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6075.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26294\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
202\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4812.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6076.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26269\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10391.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9682.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0732\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
203\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11757.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9352.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25723\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
step ii splicing factor slu7. [source:refseq;acc:nm\_006425]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9870.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10591.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07305\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
204\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase n 83 kda chain (carboxypeptidase n regulatory subunit) (fragment). [source:swissprot;acc:p22792]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10374.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9672.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07261\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme). [source:swissprot;acc:p08578]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4512.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5655.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25339\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
205\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
platelet glycoprotein v precursor (gpv) (cd42d). [source:swissprot;acc:p40197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10374.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9672.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07261\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4512.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5655.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25339\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
206\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5720.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4577.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24965\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligopeptide transporter, kidney isoform (peptide transporter 2) (kidney h+/peptide cotransporter) (solute carrier family 15, member 2). [source:swissprot;acc:q16348]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7583.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8133.08\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07247\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
207\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
asparagine synthetase [glutamine-hydrolyzing] (ec 6.3.5.4) (glutamine- dependent asparagine synthetase) (ts11 cell cycle control protein). [source:swissprot;acc:p08243]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9818\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10529.5\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4771.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5961.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24946\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
208\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-1 (e2f dimerization partner 1) (drtf1- polypeptide-1) (drtf1). [source:swissprot;acc:q14186]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6557.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7028.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07188\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4068.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5082.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24907\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
209\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10348.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9656.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0717\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4068.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5082.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24907\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
210\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding c; rag c protein. [source:refseq;acc:nm\_022157]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9371.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10040.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0714\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4068.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5082.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24906\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
211\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bet3 homolog. [source:swissprot;acc:o43617]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8749.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9372.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07119\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4068.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5082.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24905\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
212\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbp-associated factor 2; taf2 rna polymerase ii, tata box binding protein (tbp)-associated factor, 150 kd; tata box binding protein (tbp)-associated factor, rna polymerase ii, b, 150kd; cofactor of initiator function, 150kd subunit. [source:refseq;acc:nm\_003184]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6236.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6679.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07104\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4446.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5553.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24896\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/